CRISTINA EDDY: Open Payments
NPI 1285101147 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,325 in 56 payments from 13 companies in 2025. Trend: 2023 $546 · 2024 $946 · 2025 $1,325
Food & beverage: $1,318Education: $7
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $356 |
| Regeneron Healthcare Solutions, Inc. | 14 | $344 |
| GlaxoSmithKline, LLC. | 9 | $155 |
| GENZYME CORPORATION | 5 | $103 |
| Optinose US, Inc. | 4 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| CSL Behring | 2 | $58 |
| Lilly USA, LLC | 1 | $31 |
| Galderma Laboratories, L.P. | 2 | $31 |
| Incyte Corporation | 1 | $27 |
Products named: DUPIXENT, Rhapsido, Xhance, NUCALA, Andembry, TRELEGY ELLIPTA, EOHILIA, EBGLYSS.
Industry payments across WV — which companies pay providers there.
